Diagnostic validity of the generalized anxiety disorder - 7 (GAD-7) among pregnant women

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Zhong, Qiu Yue ^a   Gelaye, Bizu ^a   Zaslavsky, Alan M ^b   Fann, Jesse R ^c   Rondon, Marta B ^d   Sánchez, Sixto E ^e,f   Williams, Michelle A ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^e UNIVERSIDAD PERUANA DE CIENCIAS APLICADAS   (Peru)

^f Asociación Civil Gobierno Coherente   (Peru)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ASSESSMENT TOOL; COHORT ANALYSIS; CONCURRENT VALIDITY; CONSTRUCT VALIDITY; CONTROLLED STUDY; CRITERION RELATED VALIDITY; CRONBACH ALPHA COEFFICIENT; CROSS-SECTIONAL STUDY; CULTURAL FACTOR; FACTORIAL ANALYSIS; FEMALE; GENERALIZED ANXIETY DISORDER; GENERALIZED ANXIETY DISORDER 7; HEALTH STATUS; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MENTAL HEALTH; PERINATAL CARE; PERU; PREGNANT WOMAN; PROSPECTIVE STUDY; QUESTIONNAIRE; RASCH ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; RELIABILITY; SCORING SYSTEM; SCREENING TEST; SELF REPORT; SENSITIVITY AND SPECIFICITY; WORLD HEALTH ORGANIZATION WORLD MENTAL HEALTH COMPOSITE INTERNATIONAL DIAGNOSTIC INTERVIEW; YOUDEN INDEX; ADOLESCENT; ANXIETY DISORDERS; COMPLICATION; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS; PSYCHOLOGICAL INTERVIEW; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; REPRODUCIBILITY; YOUNG ADULT;

ADOLESCENT; ADULT; ANXIETY DISORDERS; CROSS-CULTURAL COMPARISON; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INTERVIEW, PSYCHOLOGICAL; MIDDLE AGED; PERU; PREGNANCY; PREGNANCY COMPLICATIONS; PSYCHIATRIC STATUS RATING SCALES; REPRODUCIBILITY OF RESULTS; YOUNG ADULT;

EID: 84928735804     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0125096     Document Type: Article

References (72)

1. American Psychiatric Association. The Diagnostic and Statistical Manual of Mental Disorders, 5th ed. Arlington: American Psychiatric Association, 2013.
2. Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006; 166(10):1092-1097. PMID: 16717171
3. The American Congress of Obstetricians and Gynecologists. ACOG Practice Bulletin: Clinical management guidelines for obstetrician-gynecologists number 92, April 2008 (replaces practice bulletin number 87, November 2007). Use of psychiatric medications during pregnancy and lactation. Obstet Gynecol 2008; 111(4):1001-1020. doi: 10.1097/AOG.0b013e31816fd910 PMID: 18378767
4. Alder J, Fink N, Bitzer J, Hosli I, Holzgreve W. Depression and anxiety during pregnancy: a risk factor for obstetric, fetal and neonatal outcome? A critical review of the literature. J Matern Fetal Neonatal Med 2007; 20(3):189-209. PMID: 17437220
5. de Paz NC, Sánchez SE, Huaman LE, Chang GD, Pacora PN, Garcia PJ, et al. Risk of placental abruption in relation to maternal depressive, anxiety and stress symptoms. J Affect Disord 2011; 130(1):280-284.
6. Huizink AC, Mulder EJ, Robles de Medina PG, Visser GH, Buitelaar JK. Is pregnancy anxiety a distinctive syndrome? Early Hum Dev 2004; 79(2):81-91. PMID: 15324989
7. Mulder EJ, Robles de Medina PG, Huizink AC, Van den Bergh B, Buitelaar JK, Visser GH. Prenatal maternal stress: effects on pregnancy and the (unborn) child. Early Hum Dev 2002; 70(1):3-14.
8. Qiu CF, Williams MA, Calderon-Margalit R, Cripe SM, Sorensen TK. Preeclampsia risk in relation to maternal mood and anxiety disorders diagnosed before or during early pregnancy. Am J Hypertens 2009; 22(4):397-402. doi: 10.1038/ajh.2008.366 PMID: 19197246
9. Ding X, Wu Y, Xu S, Zhu R, Jia X, Zhang S, et al. Maternal anxiety during pregnancy and adverse birth outcomes: A systematic review and meta-analysis of prospective cohort studies. J Affect Disord 2014; 159:103-110. doi: 10.1016/j.jad.2014.02.027 PMID: 24679397
10. Sutter-Dallay A, Giaconne-Marcesche V, Glatigny-Dallay E, Verdoux H. Women with anxiety disorders during pregnancy are at increased risk of intense postnatal depressive symptoms: a prospective survey of the MATQUID cohort. Eur Psychiatry 2004; 19(8):459-463. PMID: 15589703
11. Kertz SJ, Bigda-Peyton J, Bjorgvinsson T. Validity of the Generalized Anxiety Disorder-7 Scale in an Acute Psychiatric Sample. Clin Psychol Psychot 2013; 20(5):456-464. doi: 10.1002/cpp.1802 PMID: 22593009
12. Rubertsson C, Hellström J, Cross M, Sydsjö G. Anxiety in early pregnancy: prevalence and contributing factors. Arch Women Ment Hlth 2014:1-8.
13. Austin MP. Antenatal screening and early intervention for "perinatal" distress, depression and anxiety: where to from here? Arch Women Ment Hlth 2004; 7(1):1-6.
14. Löwe B, Decker O, Müller S, Brähler E, Schellberg D, Wolfgang H, et al. Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Med Care 2008; 46(3):266-274. doi: 10.1097/MLR.0b013e318160d093 PMID: 18388841
15. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380(9859):2197-2223. doi: 10.1016/S0140-6736(12)61689-4 PMID: 23245608
16. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Arlington: American Psychiatric Association, 1994.
17. Kroenke K, Spitzer RL, Williams JB, Monahan PO, Löwe B. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med 2007; 146(5):317-325. PMID: 17339617
18. Löwe B, Spitzer RL, Williams JB, Mussell M, Schellberg D, Kroenke K. Depression, anxiety and somatization in primary care: syndrome overlap and functional impairment. Gen Hosp Psychiat 2008; 30(3):191-199. doi: 10.1016/j.genhosppsych.2008.01.001 PMID: 18433651
19. Kessler RC, Üstün TB. The world mental health (WMH) survey initiative version of the world health organization (WHO) composite international diagnostic interview (CIDI). Int J Method Psych 2004; 13(2):93-121. PMID: 15297906
20. Wittchen HU. Reliability and validity studies of the WHO-Composite International Diagnostic Interview (CIDI): a critical review. J Psychiatr Res 1994; 28(1):57-84. PMID: 8064641
21. Wittchen HU, Robins LN, Cottler LB, Sartorius N, Burke JD, Regier D. Cross-cultural feasibility, reliability and sources of variance of the Composite International Diagnostic Interview (CIDI). The Multicentre WHO/ADAMHA Field Trials. Brit J Psychiat 1991; 159(5):645-653.
22. Kessler RC, Üstün TB. The WHO World Mental Health Surveys: global perspectives on the epidemiology of mental disorders. New York: Cambridge University Press, 2008.
23. Kessler RC, Brandenburg N, Lane M, Roy-Byrne P, Stang PD, Stein DJ, et al. Rethinking the duration requirement for generalized anxiety disorder: evidence from the National Comorbidity Survey Replication. Psychol Med 2005; 35(7):1073-1082. PMID: 16045073
24. Youden W. Index for rating diagnostic tests. Cancer 1950; 3(1):32-35. PMID: 15405679
25. Fluss R, Faraggi D, Reiser B. Estimation of the Youden Index and its associated cutoff point. Biom 2005; 47(4):458-472.
26. Pepe MS. The statistical evaluation of medical tests for classification and prediction. New York: Oxford University Press, 2003.
27. Begg CB, Greenes RA. Assessment of diagnostic tests when disease verification is subject to selection bias. Biometrics 1983; 39(1):207-215. PMID: 6871349
28. Kaiser HF. The application of electronic computers to factor analysis. Educ Psychol Meas 1960; 20:141-151.
29. Brown TA. Confirmatory factor analysis for applied research. New York: Guilford Press, 2006.
30. Bond TG, Fox CM. Applying the Rasch model: Fundamental measurement in the human sciences. United Kingdom: Psychology Press, 2013. doi: 10.1186/1471-2377-13-78 PMID: 23837535
31. Andrich D. A rating formulation for ordered response categories. Psychometrika 1978; 43(4):561-573.
32. Andrich D. Application of a psychometric rating model to ordered categories which are scored with successive integers. Appl Psych Meas 1978; 2(4):581-594.
33. Lamoureux EL, Tee HW, Pesudovs K, Pallant JF, Keeffe JE, Rees G. Can clinicians use the PHQ-9 to assess depression in people with vision loss? Optom Vis Sci 2009; 86(2):139-145. doi: 10.1097/OPX.0b013e318194eb47 PMID: 19156007
34. Rasch G. Probabilistic models for some intelligence and attainment tests. Chicago: MESA Press, 1993.
35. Forkmann T, Gauggel S, Spangenberg L, Brähler E, Glaesmer H. Dimensional assessment of depressive severity in the elderly general population: Psychometric evaluation of the PHQ-9 using Rasch Analysis. J Affect Disord 2013.
36. Zhong QY, Gelaye B, Fann JR, Sánchez SE, Williams MA. Cross-cultural validity of the Spanish version of PHQ-9 among pregnant Peruvian women: A Rasch Item Response Theory analysis. J Affect Disord 2014; 158:148-153. doi: 10.1016/j.jad.2014.02.012 PMID: 24655779
37. Tennant A, Conaghan PG. The Rasch measurement model in rheumatology: what is it and why use it? When should it be applied, and what should one look for in a Rasch paper? Arthritis Care Res 2007; 57(8):1358-1362. PMID: 18050173
38. Andrich D. The Rasch model explained. Applied Rasch measurement: A book of exemplars. New York: Springer, 2005.
39. Adams RJ, Wu ML, Wilson M. The Rasch rating model and the disordered threshold controversy. Educ Psychol Meas 2012; 72(4):547-573.
40. Muraki E. A generalized partial credit model: Application of an EM algorithm. Appl Psych Meas 1992; 16(2):159-176.
41. Li Y, Baser R. Using R and WinBUGS to fit a generalized partial credit model for developing and evaluating patient-reported outcomes assessments. Stat Med 2012; 31(18):2010-2026. doi: 10.1002/sim.4475 PMID: 22362655
42. Tijdink J, Smulders Y, Vergouwen A, de Vet H, Knol D. The assessment of publication pressure in medical science; validity and reliability of a Publication Pressure Questionnaire (PPQ). Qual Life Res 2014:1-8. doi: 10.1007/s11136-014-0769-6 PMID: 25218403
43. Baker FB. The basics of item response theory. ERIC, 2001. Retrieved from http://echo.edres.org:8080/irt/baker/.
44. Sidik SM, Arroll B, Goodyear-Smith F. Validation of the GAD-7 (Malay version) among women attending a primary care clinic in Malaysia. J Prim Health Care 2012; 4(1): 5-11. PMID: 22377544
45. García-Campayo J, Zamorano E, Ruiz MA, Pardo A, Pérez-Páramo M, López-Gómez V, et al. Cultural adaptation into Spanish of the generalized anxiety disorder-7 (GAD-7) scale as a screening tool. Health Qual Life Outcomes 2010; 8(8).
46. Delgadillo J, Payne S, Gilbody S, Godfrey C, Gore S, Jessop D, et al. Brief case finding tools for anxiety disorders: Validation of GAD-7 and GAD-2 in addictions treatment. Drug Alcohol Depen 2012; 125(1):37-42. doi: 10.1016/j.drugalcdep.2012.03.011 PMID: 22480667
47. Donker T, van Straten A, Marks I, Cuijpers P. Quick and easy self-rating of Generalized Anxiety Disorder: Validity of the Dutch web-based GAD-7, GAD-2 and GAD-SI. Psychiatry Res 2011; 188(1):58-64. doi: 10.1016/j.psychres.2011.01.016 PMID: 21339006
48. Abbey CK, Eckstein MP, Boone JM. Estimating the relative utility of screening mammography. Med Decis Making 2013; 33(4):510-520. doi: 10.1177/0272989X12470756 PMID: 23295543
49. Simpson W, Glazer M, Michalski N, Steiner M, Frey BN. Comparative efficacy of the generalized anxiety disorder 7-item scale and the Edinburgh Postnatal Depression Scale as screening tools for generalized anxiety disorder in pregnancy and the postpartum period. Can J Psychiatry 2014; 59(8):434-440. PMID: 25161068
50. Rothman KJ, Greenland S, Lash TL. Modern epidemiology. Philadelphia: Lippincott Williams & Wilkins, 2008.
51. Gelaye B, Williams MA, Lemma S, Deyessa N, Bahretibeb Y, Shibre T, et al. Diagnostic validity of the Composite International Diagnostic Interview (CIDI) depression module in an east African population. Int J Psychiat Med 2013; 46(4):387-405.
52. Kessler RC, Abelson J, Demler O, Escobar JI, Gibbon M, Guyer ME, et al. Clinical calibration of DSMIV diagnoses in the World Mental Health (WMH) version of the World Health Organization (WHO) Composite International Diagnostic Interview (WMH-CIDI). Int J Method Psych 2004; 13(2):122-139. PMID: 15297907
53. Kessler RC, Andrews G, Mroczek D, Üstün B, Wittchen HU. The World Health Organization Composite International Diagnostic Interview Short-Form (CIDI-SF). Int J Method Psych 1998; 7(4):171-185.
54. Bar-Shai M, Gott D, Kreinin I, Marmor S. Atypical presentations of pregnancy-specific generalized anxiety disorders in women without previous psychiatric background. Psychosomatics. Retrieved from http://www.sciencedirect.com/science/article/pii/S0033318213002491.
55. Shear MK, Mammen O. Anxiety disorders in pregnant and postpartum women. Psychopharmacol Bull 1995; 31(4):693. PMID: 8851642
56. Vythilingum B. Anxiety disorders in pregnancy. Curr Psychiatry Rep 2008; 10(4):331-335. PMID: 18627672
57. Adewuya A, Ola B, Aloba O, Mapayi B. Anxiety disorders among Nigerian women in late pregnancy: a controlled study. Arch Womens Ment Health 2006; 9(6):325-328. PMID: 17033737
58. Orr ST, Reiter JP, Blazer DG, James SA. Maternal prenatal pregnancy-related anxiety and spontaneous preterm birth in Baltimore, Maryland. Psychosom Med 2007; 69(6):566-570. PMID: 17636150
59. Van den Bergh B. The influence of maternal emotions during pregnancy on fetal and neonatal behavior. J Prenat Perinat Psychol Health 1990; 5(2).
60. Burstein I, Kinch R, Stern L. Anxiety, pregnancy, labor, and the neonate. Am J Obstet Gynecol 1974; 118(2):195-199. PMID: 4809408
61. Pompili M. Suicide: a global perspective. Sharjah: Bentham Science Publishers, 2012.
62. Garcia-Moreno C, Jansen HA, Ellsberg M, Heise L, Watts CH. Prevalence of intimate partner violence: findings from the WHO multi-country study on women's health and domestic violence. The Lancet 2006; 368(9543):1260-1269. PMID: 17027732
63. Perales MT, Cripe SM, Lam N, Sánchez SE, Sánchez E, Williams MA. Prevalence, types, and pattern of intimate partner violence among pregnant women in Lima, Peru. Violence Against Wom 2009; 15 (2):224-250. doi: 10.1177/1077801208329387 PMID: 19126836
64. McFall RM, Treat TA. Quantifying the information value of clinical assessments with signal detection theory. Annu Rev Psychol 1999; 50(1):215-241.
65. Smits N, Smit F, Cuijpers P, De Graaf R. Using decision theory to derive optimal cut-off scores of screening instruments: an illustration explicating costs and benefits of mental health screening. Int J Method Psych 2007; 16(4):219-229. doi: 10.1002/mpr.230 PMID: 18188835
66. Kraemer HC. Evaluating medical tests: Objective and quantitative guidelines. Newbury Park: Sage publications, 1992.
67. Rollman BL, Belnap BH, Mazumdar S, Houck PR, Zhu F, Gardner W, et al. A randomized trial to improve the quality of treatment for panic and generalized anxiety disorders in primary care. Arch Gen Psychiat 2005; 62(12):1332-1341. PMID: 16330721
68. Roy-Byrne P, Craske MG, Sullivan G, Rose RD, Edlund MJ, Lang AJ, et al. Delivery of evidence-based treatment for multiple anxiety disorders in primary care: a randomized controlled trial. JAMA 2010; 303 (19):1921-1928. doi: 10.1001/jama.2010.608 PMID: 20483968
69. Portman ME, Starcevic V, Beck AT. Challenges in assessment and diagnosis of generalized anxiety disorder. Psychiatr Ann 2011; 41(2):79-85.
70. García-Campayo J, Zamorano E, Ruiz MA, Pérez-Páramo M, López-Gómez V, Rejas J. The assessment of generalized anxiety disorder: psychometric validation of the Spanish version of the self-administered GAD-2 scale in daily medical practice. Health Qual Life Outcomes 2012; 10:114. doi: 10.1186/1477-7525-10-114 PMID: 22992432
71. Wetzel E, Carstensen CH. Reversed Thresholds in Partial Credit Models A Reason for Collapsing Categories? Assessment 2014. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24789857.
72. Ruiz MA, Zamorano E, García-Campayo J, Pardo A, Freire O, Rejas J. Validity of the GAD-7 scale as an outcome measure of disability in patients with generalized anxiety disorders in primary care. J Affect Disorders 2011; 128(3):277-286. doi: 10.1016/j.jad.2010.07.010 PMID: 20692043